A genetic variant nearGATA3implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)-Reference-Cited by-同舟云学术

A genetic variant nearGATA3implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)

Published:2017-06-28 Issue:11 Volume:77 Page:1213-1220
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Na Rong¹²³,Helfand Brian T.¹⁴,Chen Haitao⁵,Conran Carly A.¹,Crawford Susan E.¹,Hayward Simon W.¹,Tammela Teuvo L.J.⁶,Hoffman-Bolton Judy⁷,Zheng Siqun L.¹,Walsh Patrick C.⁸,Schleutker Johanna⁹,Platz Elizabeth A.⁷,Isaacs William B.⁸¹⁰,Xu Jianfeng¹²^ORCID

Affiliation:

1. Program for Personalized Cancer Care; NorthShore University HealthSystem; Evanston Illinois

2. Fudan Institute of Urology, Huashan Hospital; Fudan University; Shanghai China

3. Fudan Universtiy Shanghai Medical College; Shanghai; China

4. Department of Surgery; NorthShore University HealthSystem; Evanston Illinois

5. Fudan University School of Public Health; Shanghai; China

6. Department of Urology, Tampere University Hospital and Medical School; University of Tampere; Tampere Finland

7. Department of Epidemiology; Johns Hopkins University Bloomberg School of Public Health; Baltimore Maryland

8. Department of Urology and the James Buchanan Brady Urologic Institute; Johns Hopkins University School of Medicine; Baltimore Maryland

9. Department of Medical Biochemistry and Genetics; University of Turku; Turku Finland

10. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland

Funder

GlaxoSmithKline

National Institute of Diabetes and Digestive and Kidney Diseases

National Cancer Institute

Publisher

Wiley

Subject

Urology,Oncology

Reference30 articles.

1. Epidemiology and natural history of benign prostatic hyperplasia;Barry;Urol Clin North Am,1990

2. The economics of medical therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia;Nickel;Curr Urol Rep,2006

3. The pathogenesis of benign prostatic hyperplasia;Wilson;Am J Med,1980

4. Metabolic factors associated with benign prostatic hyperplasia;Parsons;J Clin Endocrinol Metab,2006

5. PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia;Jiang;Differentiation,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biology, genetic, and epigenetics of prostate disease;Genetics and Epigenetics of Genitourinary Diseases;2025

2. Inheritance patterns of lower urinary tract symptoms in adults: a systematic review;BJU International;2024-08-26

3. Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis;Medicine;2024-03-01

4. Genetic, Genomic, and Heritable Components of Benign Prostatic Hyperplasia;Current Bladder Dysfunction Reports;2023-04-20

5. Impact of the bladder detrusor muscular ring on lower urinary tract symptoms due to benign prostatic hyperplasia: A quantitative MRI analysis;The Prostate;2022-11-07